To prohibit brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products, and for other purposes.

United States Government Publishing Office publisher pbl distributor dst United States Congress House of Representatives author aut Government Organization text government publication eng BILLS To prohibit brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products, and for other purposes.;Protecting Consumer Access to Generic Drugs Act of 2021;H.R. 153 (IH) Bills and Statutes 117_cong_bills legislative 2021-02-04 To prohibit brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products, and for other purposes. Protecting Consumer Access to Generic Drugs Act of 2021 H.R. 153 (IH) U.S. Government Publishing Office 2021-01-04 monographic deposited born digital 20 p. Y 1.6: Y 1.4/6: P0b002ee1ab3783cd https://www.govinfo.gov/app/details/BILLS-117hr153ih H.R. 153 021-610-00252-9 000501532 000325573 Congressional bills House bills f:h153_ih.txt https://www.govinfo.gov/app/details/BILLS-117hr153ih https://www.govinfo.gov/content/pkg/BILLS-117hr153ih/html/BILLS-117hr153ih.htm https://www.govinfo.gov/content/pkg/BILLS-117hr153ih/pdf/BILLS-117hr153ih.pdf https://www.govinfo.gov/content/pkg/BILLS-117hr153ih/xml/BILLS-117hr153ih.xml fdlp DGPO 2021-02-04 2022-12-31 BILLS-117hr153ih machine generated eng Bobby L. Rush United States House of Representatives sponsor spn United States Congress Member Sean Casten United States House of Representatives cosponsor United States Congress Member Steve Cohen United States House of Representatives cosponsor United States Congress Member Gerald E. Connolly United States House of Representatives cosponsor United States Congress Member Mark DeSaulnier United States House of Representatives cosponsor United States Congress Member Joe Neguse United States House of Representatives cosponsor United States Congress Member Raul Ruiz United States House of Representatives cosponsor United States Congress Member Lauren Underwood United States House of Representatives cosponsor United States Congress Member Jefferson Van Drew United States House of Representatives cosponsor United States Congress Member United States Congress House of Representatives Committee on Energy and Commerce associated name asn United States Congress House of Representatives Committee on the Judiciary associated name asn United States Code Title 5 Section 553 5 U.S.C. 553 United States Code Title 15 Section 12(a) Title 15 Section 41et seq. Title 15 Section 45 Title 15 Section 45(a)(1) Title 15 Section 45(a)(2) Title 15 Section 45(g) Title 15 Section 45(g)(1) Title 15 Section 45(l) Title 15 Section 56(a)(2) 15 U.S.C. 12(a) 15 U.S.C. 41et seq. 15 U.S.C. 45 15 U.S.C. 45(a)(1) 15 U.S.C. 45(a)(2) 15 U.S.C. 45(g) 15 U.S.C. 45(g)(1) 15 U.S.C. 45(l) 15 U.S.C. 56(a)(2) United States Code Title 21 Section 321(g) Title 21 Section 355a Title 21 Section 355(b)(1) Title 21 Section 355(b)(2) Title 21 Section 355(c)(3)(E) Title 21 Section 355(j) Title 21 Section 355(j)(5)(B)(iv) Title 21 Section 355(j)(5)(D)(i)(V) Title 21 Section 355(j)(5)(F) Title 21 Section 355(j)(7) Title 21 Section 355note Title 21 Section 355f Title 21 Section 360cc 21 U.S.C. 321(g) 21 U.S.C. 355a 21 U.S.C. 355(b)(1) 21 U.S.C. 355(b)(2) 21 U.S.C. 355(c)(3)(E) 21 U.S.C. 355(j) 21 U.S.C. 355(j)(5)(B)(iv) 21 U.S.C. 355(j)(5)(D)(i)(V) 21 U.S.C. 355(j)(5)(F) 21 U.S.C. 355(j)(7) 21 U.S.C. 355note 21 U.S.C. 355f 21 U.S.C. 360cc United States Code Title 42 Section 262 Title 42 Section 262(a) Title 42 Section 262(i) Title 42 Section 262(k) Title 42 Section 262(k)(6) 42 U.S.C. 262 42 U.S.C. 262(a) 42 U.S.C. 262(i) 42 U.S.C. 262(k) 42 U.S.C. 262(k)(6) United States Statutes at Large Volume 124 Page 817 124 Stat. 817 United States Public Law 148 (111th Congress) Public Law 111-148 hr BILLS-117hr153ih 117 1 HOUSE HOUSE 153 ih ih Protecting Consumer Access to Generic Drugs Act of 2021 To prohibit brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products, and for other purposes. Mr. Rush (for himself, Mr. Casten, Mr. Cohen, Mr. Connolly, Mr. DeSaulnier, Mr. Neguse, Mr. Ruiz, Ms. Underwood, and Mr. Van Drew) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned Committee on Energy and Commerce Energy and Commerce Committee on the Judiciary Judiciary Mr. Rush Bobby L. Rush Rush, Bobby L. Bobby Rush Mr. Casten Sean Casten Casten, Sean Mr. Cohen Steve Cohen Cohen, Steve Mr. Connolly Gerald E. Connolly Connolly, Gerald E. Mr. Gerald Connolly Mr. DeSaulnier Mark DeSaulnier DeSaulnier, Mark Mr. Neguse Joe Neguse Neguse, Joe Mr. Ruiz Raul Ruiz Ruiz, Raul Ms. Underwood Lauren Underwood Underwood, Lauren Mr. Van Drew Jefferson Van Drew Van Drew, Jefferson false false